You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 20, May 27, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Medical Ethics
 •Women's Health
 •Pregnancy and Breast Feeding
 •Diagnosis
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Practical and Ethical Considerations of Noninvasive Prenatal Diagnosis

Peter A. Benn, PhD, DSc; Audrey R. Chapman, PhD

JAMA. 2009;301(20):2154-2156.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Chromosome abnormalities such as trisomy 21 (Down syndrome), other autosomal trisomies, sex chromosome abnormalities, and balanced and unbalanced translocations can be prenatally diagnosed. For many individuals, the availability of prenatal diagnosis removes the fear of having a child with a severe physical or mental disability. For chromosome abnormalities that are associated with significant morbidity and mortality, the public's acceptance of prenatal diagnosis has been well established during the past 4 decades during which testing has been available.

Current standards of care involve screening women to identify those at highest risk of having a fetus with a chromosome abnormality and then offering definitive diagnosis through the analysis of a chorionic villus sample or amniotic fluid cells. The American College of Obstetricians and Gynecologists recommends that all women be offered aneuploidy screening through various combinations of maternal serum tests and sonographic measurements.1 However, . . . [Full Text of this Article]

Practical Issues

Author Affiliations: Division of Human Genetics, Department of Genetics and Developmental Biology (Dr Benn), and Department of Community Medicine and Health Care (Dr Chapman), University of Connecticut Health Center, Farmington.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.